Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of 1350.46 pence per Ordinary share on 6 October 2011 through the Company's Share Reward Plan ("the Plan").
Mr A P Witty |
Acquisition of 34 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S M Bicknell |
Acquisition of 34 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S Dingemans |
Acquisition of 1 Ordinary share under the Dividend Reinvestment element of the Plan
|
Mr E J Gray |
Acquisition of 34 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S A Hussain |
Acquisition of 6 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr D Pulman |
Acquisition of 10 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr D S Redfern |
Acquisition of 34 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Ms C Thomas |
Acquisition of 34 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr P C Thomson |
Acquisition of 14 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr P J T Vallance |
Acquisition of 14 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mrs V A Whyte |
Acquisition of 26 Ordinary shares under the Dividend Reinvestment element of the Plan
|
The Company and the above-mentioned persons were advised of this information on 7 October 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
7 October 2011